Back to News
Market Impact: 0.05

Monthly Factsheet

Emerging MarketsCompany FundamentalsRegulation & LegislationManagement & Governance

Fidelity Emerging Markets Limited (LEI: 213800HWWQPUJ4K1GS84) published its monthly factsheet as at 30 November 2025; the latest factsheet is available on the company's website. Copies have been submitted to the UK Listing Authority and will be uploaded to the National Storage Mechanism for inspection, typically within two business days of this notice (dated 23 December 2025).

Analysis

Market structure: The monthly factsheet release increases short-term transparency for Fidelity Emerging Markets Limited (closed-end), favoring arbitrageurs and active managers who trade the NAV/price discount. Winners: buyers of EM beta (EEM, VWO) and discount-arbitrageurs if the trust’s discount is >8% for sustained periods; losers: passive holders of the trust when discount widens and short-term liquidity providers if volume spikes. Supply/demand: factsheet visibility can trigger modest inflows (estimate 0.5–2% of AUM over 30–90 days) reducing discount pressure; large redemptions are unlikely because it’s closed-end but secondary market liquidity can amplify moves. Risk assessment: Tail risks include sudden governance moves (suspension of buybacks or a levering decision), China regulatory shocks or a USD rate surprise that widens discounts by 500–800bps; probability low but impact high. Immediate (days): NAV repricing; short-term (30–90 days): discount compression/expansion driven by flows and macro; long-term (quarters): manager performance and dividend policy drive fundamental re-rating. Hidden dependencies: trust gearing, top-10 holding concentration, and dividend yield drive mismatch versus ETFs; catalysts include MSCI rebalances, UK dividend season, and Fed decisions. Trade implications: Direct play — establish a 2–3% portfolio long in Fidelity Emerging Markets Limited (LSE: FEM.L) if market price trades at an >=8% discount to reported NAV for five consecutive sessions, target 6–12 month hold, stop-loss if discount widens to >15% or price falls 12%. Relative value — pair trade: long VWO 2% vs short FEM.L 1.5% to capture persistent discount compression over 60–120 days; close if spread tightens to <100bps. Options — if expecting short-term EM inflows, buy a 3-month EEM (ticker EEM) 5% OTM call spread sized 1% portfolio risk; protective puts on FEM.L if downside skew rises. Contrarian angles: The market may underprice the closed‑end discount arbitrage potential — discounts historically overshoot by 3–8% before mean reversion (see 2019–2021 closed‑end behavior). Reaction could be underdone: if FEM.L shows top‑10 holdings concentrated and outperformed benchmarks, the discount may compress quickly on even modest inflows. Unintended consequence: flows into ETFs (EEM/VWO) can concentrate liquidity risk in a handful of large caps; monitor top-5 weight >25% as a stress trigger.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Key Decisions for Investors

  • Establish a 2–3% long position in Fidelity Emerging Markets Limited (LSE: FEM.L) only if the market price trades at an >=8% discount to reported NAV for five consecutive trading days; target 6–12 months, take profits when discount narrows to <3%, and cut if discount widens to >15% or price drops 12%.
  • Deploy 2–4% portfolio in broad EM beta via EEM or VWO (ticker EEM/VWO) over a 3–6 month horizon to capture potential EM inflows; alternatively size a 1% notional 3‑month EEM 5% OTM call spread if seeking asymmetric upside with limited downside.
  • Implement a pair trade: long VWO (2% portfolio) vs short FEM.L (1.5%) to capture discount compression; unwind after 60–120 days or when performance differential tightens to <100bps.
  • Monitor FEM.L monthly factsheet metrics daily for 30–60 days: if top‑10 holdings concentration >30%, gearing >10%, or 12‑month underperformance vs MSCI EM exceeds 300bps, rotate out of FEM.L into ETFs (sell FEM.L, buy EEM/VWO) within 30 days to reduce manager/concentration risk.